Anemia, which is the consequence of the insufficient production of EPO and a higher demand for EPO, is another critical complication of ESRD and leads to insufficient Hb and RBC production (Santoro and Canova, 2005; van der Meer et al., 2008; Yokoro et al., 2017). Here, GSTM1 is linked to anemia.